|
mendelian randomization |
14 |
|
testosterone |
14 |
|
chinese |
13 |
|
secondary prevention |
13 |
|
vitamin d |
13 |
|
ischemic stroke |
12 |
|
myocardial infarction |
12 |
|
recurrence |
12 |
|
exome chip |
10 |
|
hypertension |
10 |
|
type 2 diabetes |
10 |
|
mendelian randomization analysis |
8 |
|
qt interval |
7 |
|
diabetes |
6 |
|
berberine |
5 |
|
blood pressure |
5 |
|
cardiovascular risk factors |
5 |
|
estrogen |
5 |
|
menarche |
5 |
|
menarcheal age |
5 |
|
puberty |
5 |
|
randomized controlled trial |
5 |
|
women |
5 |
|
cardiovascular disease |
4 |
|
causal effect |
4 |
|
instrumental variable estimate |
4 |
|
ischemic heart disease |
4 |
|
meta-analysis |
4 |
|
ace inhibitor |
3 |
|
aspartate |
3 |
|
competing risk |
3 |
|
covid-19 |
3 |
|
e-cigarettes |
3 |
|
glucose |
3 |
|
glycated hemoglobin |
3 |
|
immune function |
3 |
|
inflammation |
3 |
|
instrumental variable analysis |
3 |
|
insulin resistance |
3 |
|
random allocation |
3 |
|
randomization mr |
3 |
|
selection bias |
3 |
|
shared etiology |
3 |
|
smoking |
3 |
|
unsaturated fatty acid |
3 |
|
androgen |
2 |
|
androgens |
2 |
|
antihypertensives |
2 |
|
arachidonic acid |
2 |
|
asthma |
2 |
|
atherosclerotic cardiovascular disease |
2 |
|
big data |
2 |
|
cardiovascular |
2 |
|
cerebrovascular accident |
2 |
|
chronic disease |
2 |
|
chronic diseases |
2 |
|
chronic kidney disease |
2 |
|
clinical trial (topic) |
2 |
|
coagulation |
2 |
|
dietary intake |
2 |
|
fads1 gene |
2 |
|
fads2 gene |
2 |
|
folate |
2 |
|
gender difference |
2 |
|
gene |
2 |
|
genetic analysis |
2 |
|
heart diseases |
2 |
|
heart rate |
2 |
|
human |
2 |
|
kidney function |
2 |
|
linoleic acid |
2 |
|
lipids |
2 |
|
men |
2 |
|
mendelian randomisation |
2 |
|
obesity |
2 |
|
renal function |
2 |
|
risk factors |
2 |
|
sex disparity |
2 |
|
sex hormone binding globulin |
2 |
|
thrombin |
2 |
|
von willebrand factor |
2 |
|
white blood cell |
2 |
|
citation bias |
1 |
